SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001764013-23-000063
Filing Date
2023-05-22
Accepted
2023-05-22 07:03:03
Documents
21
Period of Report
2023-05-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imvt-20230522.htm   iXBRL 8-K 36979
2 EX-99.1 exhibit99120220522.htm EX-99.1 85775
3 EX-99.2 exhibit992.htm EX-99.2 8866
7 GRAPHIC exhibit992001.jpg GRAPHIC 91506
8 GRAPHIC exhibit992002.jpg GRAPHIC 211368
9 GRAPHIC exhibit992003.jpg GRAPHIC 92884
10 GRAPHIC exhibit992004.jpg GRAPHIC 80316
11 GRAPHIC exhibit992005.jpg GRAPHIC 100829
12 GRAPHIC exhibit992006.jpg GRAPHIC 85189
13 GRAPHIC exhibit992007.jpg GRAPHIC 85601
  Complete submission text file 0001764013-23-000063.txt   1311699

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20230522.xsd EX-101.SCH 1896
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20230522_lab.xml EX-101.LAB 23832
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20230522_pre.xml EX-101.PRE 12504
15 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20230522_htm.xml XML 10819
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38906 | Film No.: 23942410
SIC: 2836 Biological Products, (No Diagnostic Substances)